Contact Us

Defective Drugs
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Name of drug: 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Headlines by Topic

Xolair

Xolair Being Investigated for Possible Link to Heart Problems, Strokes

Jul 17, 2009
| Parker Waichman LLP
The asthma drug Xolair is undergoing a Food & Drug Administration (FDA) safety review because of a possible link to heart problems and...

Xolair Linked to Risk for Delayed-Onset Anaphylaxis

Feb 22, 2007
| www.medscape.com
Omalizumab subcutaneous injection (Xolair, made by Genentech, Inc) may be linked to life-threatening anaphylaxis, according to a warning from the US...

FDA Issues New Warning About Asthma Drug Xolair

Feb 22, 2007
| NewsInferno.com
Citing reports of severe, potentially fatal allergic reactions, the U.S. Food and Drug Administration (FDA) has issued a new warning about...

FDA orders stronger asthma drug warning

Feb 21, 2007
| AP
The government ordered stronger label warnings for an injected asthma medication Wednesday because of reports some patients taking the drug, marketed...

FDA Proposes to Strengthen Label Warning for Xolair

Feb 21, 2007
| www.fda.gov
The Food and Drug Administration (FDA) announced that it has requested Genentech, Inc. add a boxed warning to the product label for omalizumab,...

FDA orders warnings for Xolair

Feb 21, 2007
| UPI
The U.S. Food and Drug Administration ordered Genentech Inc. to add a boxed warning to its asthmatic drug marketed as Xolair. The FDA said the boxed...

Page 1/1

Law Dragon Best Lawyers Peer Review Rated Avvo Protected by Copyscape Web Copyright Protection Software php-5